BioCentury
ARTICLE | Company News

Genta, Baxter Healthcare Corp. deal

October 9, 1995 7:00 AM UTC

The companies will conduct a feasibility study of the ability of certain Anticode oligonucleotides to promote the death of mature human T cells. GNTA (San Diego) and Baxter believe that inducing matur...